Abstract
Glomerular filtration rate (GFR) and renal uptake of dimercaptosuccinic acid (DMSA) were measured in 31 patients with progressive chronic nephropathy before and immediately after the start of treatment with angiotensin converting enzyme (ACE) inhibitor in order to control adverse effects on kidney function. Scintigrams of the kidneys showed an unaltered distribution of DMSA during treatment. GFR estimated by 51Cr-EDTA plasma clearance fell by 14% (P less than 0.01), but renal uptake of 99mTc-DMSA increased by 10% (P less than 0.01). It is concluded that DMSA in chronic renal failure is mainly taken up by the tubular cells from the peritubular capillaries since the uptake was unaffected by the acute decrease in GFR.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | European Journal of Nuclear Medicine and Molecular Imaging |
| Vol/bind | 16 |
| Udgave nummer | 2 |
| Sider (fra-til) | 85-8 |
| Antal sider | 4 |
| ISSN | 0340-6997 |
| Status | Udgivet - 1990 |